Loading
Latest filing published 19 Jul 2021 for American BIO Medica CORP, €26k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
John J. Moroney is a declared insider of American BIO Medica Corp (chief executive), with filings sourced from SEC (Form 4). We count 5 filings; the first trade dates from 29 January 2016 and the latest from 15 July 2021.
No open-market purchase appears, only 1 sale worth €26k. So far in 2021, the count stands at no purchases and 1 sale.
On 19 July 2021 came the latest disclosure, an open-market sale for €26k in American BIO Medica Corp. The median gap between a trade and its publication by SEC (Form 4) is 9 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration